Verastem (VSTM) Return on Capital Employed (2012 - 2026)

Verastem's (VSTM) quarterly Return on Capital Employed came in at 100.34% in Q1 2026, up 6148.0% year-on-year from 1.61% in Q1 2025, and up 17.8% quarter-over-quarter from 122.06% in Q4 2025.

Verastem (VSTM) Return on Capital Employed (2012 - 2026) Analysis & Trends

Verastem's Return on Capital Employed history runs 15 years deep, the most recent figure standing at 100.34% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 6148.0% year-over-year to 100.34% in Q1 2026; TTM through Mar 2026 was 100.34%, a 6148.0% increase from a year earlier, with the FY2025 full-year figure at 167.25%, down 4580.0% from the prior year.
  • Return on Capital Employed improved to 100.34% in Q1 2026 per VSTM's latest filing, from 122.06% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 48.58% in Q3 2023 and bottomed at 161.82% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 91.72% (2024), against an average of 101.32%.
  • Across the five-year window, Return on Capital Employed tumbled 9694 bps in 2024 and surged 6148 bps in 2026, its largest moves.
  • Year by year, Return on Capital Employed stood at 89.59% in 2022, then increased by 25 bps to 67.43% in 2023, then sank by 105 bps to 138.53% in 2024, then advanced by 12 bps to 122.06% in 2025, then gained by 18 bps to 100.34% in 2026.
  • Per Business Quant, the three latest VSTM Return on Capital Employed figures stand at 100.34% (Q1 2026), 122.06% (Q4 2025), and 126.33% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -31.80%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.46%
4 NuCana 279.75 Bn 279.75 Bn - -68.47%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 10.19%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -68.84%
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn -100.34%

Historic Data

Download Data
DateValue
Mar 31, 2026 -100.34%
Dec 31, 2025 -122.06%
Sep 30, 2025 -126.33%
Jun 30, 2025 -137.79%
Mar 31, 2025 -161.82%
Dec 31, 2024 -138.53%
Sep 30, 2024 -145.52%
Jun 30, 2024 -117.19%
Mar 31, 2024 -91.72%
Dec 31, 2023 -67.43%
Sep 30, 2023 -48.58%
Jun 30, 2023 -54.74%
Mar 31, 2023 -87.96%
Dec 31, 2022 -89.59%
Sep 30, 2022 -86.56%
Jun 30, 2022 -79.08%
Mar 31, 2022 -67.30%
Dec 31, 2021 -66.98%
Sep 30, 2021 -59.08%
Jun 30, 2021 -27.02%